Why is Senores Pharma. falling/rising?

As of 04-Aug, Senores Pharmaceuticals Ltd is experiencing a rise in its stock price, currently at 695.00, reflecting an increase of 29.65 or 4.46%. The stock has shown strong performance recently, with a 1-week return of 8.10% and a 1-month return of 22.55%, significantly outperforming the Sensex, which has declined by 2.89% over the same period. Today's performance indicates a trend reversal as the stock has gained after three consecutive days of decline, reaching an intraday high of Rs 699.9. Additionally, the company has demonstrated healthy growth metrics, with net sales increasing at an annual rate of 85.60% and operating profit rising at 130.72%. However, there are concerns regarding falling investor participation, as delivery volume has decreased significantly, indicating a potential lack of interest among retail investors.
In the broader market context, while Senores Pharmaceuticals has outperformed the Sensex in both the short term and year-to-date, the overall market sentiment may be influenced by the declining participation of institutional investors, who have reduced their stake in the company. This could suggest a cautious outlook from more experienced investors, despite the company's strong financial performance and low debt levels. The stock's valuation is considered expensive, with a price-to-book value of 4.1, which may also contribute to the mixed sentiment surrounding its future prospects.